Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Skin Elements Limited ( (AU:SKN) ) has issued an update.
Skin Elements Limited has received a further shareholder requisition under section 249D of the Corporations Act from Kingsbury Wealth, which holds 7.3% of the company and is controlled by director Roderick Nicholas, calling for a general meeting to overhaul the board. The notice seeks to remove recently appointed directors Stuart Usher, Brett Fraser and Robin Armstrong and replace them with proposed directors Frank Knezovic, Gorakanage Ishan Malinda Peries and Harry Michael Spindler, signalling an escalating governance dispute and potential shift in strategic control, with a meeting to be convened within statutory timeframes.
The company has confirmed it will call the requisitioned meeting within 21 days and hold it within two months, as required by law, with a detailed notice of meeting to follow. The move underscores growing tension between factions on the register and may introduce uncertainty around leadership and strategy for investors and other stakeholders, as the outcome could reshape the composition and direction of the board in the near term.
More about Skin Elements Limited
Skin Elements Limited is an ASX-listed Australian biotechnology healthcare company focused on commercialising its proprietary anti-microbial SE Formula through natural and organic health care products. Its global portfolio spans plant-based personal care and skincare, including SuprCuvr hospital-grade disinfectant, Eco Nurture plant bio-stimulant, Invisi Shield sanitiser, Soléo Organics sunscreen, PapayaActivs therapeutics skincare and Elizabeth Jane Natural Cosmetics.
Current Market Cap: A$15.23M
For detailed information about SKN stock, go to TipRanks’ Stock Analysis page.